Sumitomo Chemical India Limited has announced an earnings call with investors and analysts to discuss its financial performance for Q4 and the full year FY26. The call is scheduled for Thursday, 28th May, 2026, at 2:00 pm IST, as intimated to stock exchanges pursuant to Regulation 30(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Earnings Call Details

The conference call will focus on the company's financial results for the quarter and year ended 31st March, 2026. Participants can join via dial-in access numbers or through the Diamond Pass link provided in the earnings call invite, which is also hosted on the company's official website at www.sumichem.co.in .

The following access numbers have been made available for the call:

Senior Management Participation

The earnings call will feature participation from Sumitomo Chemical India's senior leadership team. The following executives are scheduled to be present:

• Mr. Chetan Shah – Managing Director
• Mr. Sushil Marfatia – Executive Director
• Dr. Suresh Ramachandran – Deputy Managing Director
• Mr. Kunal Mittal – Sr. VP, Planning & Co-ordination Office
• Mr. Anil Nawal – Chief Financial Officer
• Mrs. Deepika Trivedi – Company Secretary & Compliance Officer

RSVP and Coordination

The earnings call is being coordinated by Strategic Growth Advisors Pvt. Ltd. Interested participants may RSVP through Jigar Kavaiya or Parin Narichania, reachable at +91 99206 02034 and +91 99300 25733, respectively. The formal intimation was signed by Deepika Trivedi, Company Secretary, on 14th May, 2026.

Sumitomo Chemical India Limited has informed the stock exchanges that a meeting of its Board of Directors is scheduled to be held on Tuesday, May 26, 2026. The intimation was made in accordance with Regulation 29(1)(a) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company's scrip code is 542920, and it is listed under the symbol SUMICHEM.

Agenda for the Board Meeting

The primary agenda for the upcoming board meeting includes two key items. First, the directors will consider the audited financial statements of the company, both standalone and consolidated, for the financial year ended March 31, 2026. Second, the board will deliberate on the recommendation of a dividend, if any, on equity shares for the financial year 2025-26.

Key Details

The intimation was addressed to the Listing Departments of BSE Limited and The National Stock Exchange of India. The communication was signed by Deepika Trivedi, Company Secretary & Compliance Officer, on behalf of Sumitomo Chemical India Limited.